Testing PARP inhibitors using a murine xenograft model

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Animal models are indispensable research tools for various drug discovery and development applications. In cancer research, the growth of tumors in vivo is necessary in order to closely modulate a potential response in humans. Ectopic (subcutaneous) xenografting of human cancer cells into immunodeficient mice has long been the standard model for preclinical evaluation of novel antitumor therapeutic agents. Here, we describe the establishment and use of subcutaneous xenograft mouse model to evaluate the antitumor activity of PARP-1 inhibitors.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages313-320
Number of pages8
DOIs
StatePublished - 2017

Publication series

NameMethods in Molecular Biology
Volume1608
ISSN (Print)1064-3745

Keywords

  • Cancer
  • Model
  • Mouse
  • PARP-1
  • Subcutaneous
  • Xenograft

Fingerprint

Dive into the research topics of 'Testing PARP inhibitors using a murine xenograft model'. Together they form a unique fingerprint.

Cite this